tirzepatide life md Oral Tirzepatide | DirectMeds

History, medication review, and health assessment

Dual GIP + GLP-1 agonist Member results A stronger next step for members who need better hunger control or fresh momentum

This class of medications has a robust clinical track record, having been safely utilized and studied for diabetes care for over two decades

More significant structural improvements reduced fine lines, improved firmness, better skin density typically become visible between weeks 8 and 12, with continued improvement through months 4 to 6 as collagen remodeling matures

The marketing authorization holder for this medicinal product is Novo Nordisk A/S